Premium
Periodontal regeneration using an injectable bone cement combined with BMP‐2 or FGF‐2
Author(s) -
Oortgiesen Daniël AW,
Walboomers X Frank,
Bronckers Antonius LJJ,
Meijer Gert J,
Jansen John A
Publication year - 2014
Publication title -
journal of tissue engineering and regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.835
H-Index - 72
eISSN - 1932-7005
pISSN - 1932-6254
DOI - 10.1002/term.1514
Subject(s) - periodontal fiber , bone healing , bone morphogenetic protein 2 , dentistry , periodontitis , medicine , bone morphogenetic protein , fibroblast growth factor , resorption , regeneration (biology) , chemistry , surgery , biology , microbiology and biotechnology , receptor , biochemistry , in vitro , gene
Periodontitis is a frequently diagnosed oral disease characterized by bone resorption and soft tissue loss around teeth. Unfortunately, currently available therapies only slow or arrest progress of the disease. Ideally, treatment of periodontal defects should be focused on complete regeneration of the lost tissues [(bone and periodontal ligament (PDL)]. As a result, this study used intrabony defects to evaluate the regenerative potential of an injectable macroporous calcium phosphate cement (CaP) in combination with bone morphogenetic protein‐2 (BMP‐2) or fibroblast growth factor‐2 (FGF‐2). After creating 30 periodontal defects in 15 Wistar rats, three treatment strategies were conducted: application of CaP only, CaP + BMP‐2 and CaP + FGF‐2. Animals were euthanized after 12 weeks and processed for histology and histomorphometry. Using CaP alone resulted in limited effects on PDL and bone healing. CaP + BMP‐2 showed a good response for bone healing; a significant 2.4 fold increase in bone healing score was observed compared to CaP. However, for PDL healing, CaP + BMP‐2 treatment showed no difference compared to the CaP group. The best results were observed with the combined treatment of CaP + FGF‐2, which showed a significant 3.3 fold increase in PDL healing score compared to CaP + BMP‐2 and a significant 2.6 fold increase compared to CaP. For bone healing, CaP + FGF‐2 showed a significant 1.9 fold increase compared to CaP but no significant difference was noted compared to the CaP + BMP‐2 group. The combination of a topical application of FGF‐2 and an injectable CaP seems to be a promising treatment modality for periodontal regeneration. Copyright © 2012 John Wiley & Sons, Ltd.